Detalhe da pesquisa
1.
Reliability of flow-cytometry in diagnosis and prognostic stratification of myelodysplastic syndromes: correlations with morphology and mutational profile.
Ann Hematol
; 102(11): 3015-3023, 2023 Nov.
Artigo
Inglês
| MEDLINE | ID: mdl-37535147
2.
Clinical relevance of an objective flow cytometry approach based on limit of detection and limit of quantification for measurable residual disease assessment in acute myeloid leukemia. A post-hoc analysis of the GIMEMA AML1310 trial.
Haematologica
; 107(12): 2823-2833, 2022 12 01.
Artigo
Inglês
| MEDLINE | ID: mdl-35295076
3.
GIMEMA AML1310 trial of risk-adapted, MRD-directed therapy for young adults with newly diagnosed acute myeloid leukemia.
Blood
; 134(12): 935-945, 2019 09 19.
Artigo
Inglês
| MEDLINE | ID: mdl-31395600
4.
Clinical significance of occult central nervous system disease in adult acute lymphoblastic leukemia. A multicenter report from the Campus ALL Network.
Haematologica
; 106(1): 39-45, 2021 01 01.
Artigo
Inglês
| MEDLINE | ID: mdl-31879328
5.
Applicability and reproducibility of acute myeloid leukaemia stem cell assessment in a multi-centre setting.
Br J Haematol
; 190(6): 891-900, 2020 09.
Artigo
Inglês
| MEDLINE | ID: mdl-32239670
6.
Minimal residual disease as biomarker for optimal biologic dosing of ARA-C in patients with acute myeloid leukemia.
Am J Hematol
; 90(2): 125-31, 2015 Feb.
Artigo
Inglês
| MEDLINE | ID: mdl-25377359
7.
High sensitivity of flow cytometry improves detection of occult leptomeningeal disease in acute lymphoblastic leukemia and lymphoblastic lymphoma.
Ann Hematol
; 93(9): 1509-13, 2014 Sep.
Artigo
Inglês
| MEDLINE | ID: mdl-24752416
8.
Longitudinal detection of DNMT3AR882H transcripts in patients with acute myeloid leukemia.
Am J Hematol
; 93(5): E120-E123, 2018 05.
Artigo
Inglês
| MEDLINE | ID: mdl-29417611
9.
Direct CD32 T-cell cytotoxicity: implications for breast cancer prognosis and treatment.
Life Sci Alliance
; 5(12)2022 12.
Artigo
Inglês
| MEDLINE | ID: mdl-36241426
10.
ELN2017 risk stratification improves outcome prediction when applied to the prospective GIMEMA AML1310 protocol.
Blood Adv
; 6(8): 2510-2516, 2022 04 26.
Artigo
Inglês
| MEDLINE | ID: mdl-34731884
11.
Use of Measurable Residual Disease to Evolve Transplant Policy in Acute Myeloid Leukemia: A 20-Year Monocentric Observation.
Cancers (Basel)
; 13(5)2021 Mar 03.
Artigo
Inglês
| MEDLINE | ID: mdl-33802502
12.
Prognostic impact of ZAP-70 expression in chronic lymphocytic leukemia: mean fluorescence intensity T/B ratio versus percentage of positive cells.
J Transl Med
; 8: 23, 2010 Mar 08.
Artigo
Inglês
| MEDLINE | ID: mdl-20211015
13.
CD34 + CD38-CLL1+ leukemic stem cells persistence measured by multiparametric flow cytometry is a biomarker of poor prognosis in adult patients with acute myeloid leukemia.
Leuk Lymphoma
; 63(4): 996-1000, 2022 04.
Artigo
Inglês
| MEDLINE | ID: mdl-34806525
14.
Occult central nervous system involvement guides therapeutic choices in blastic plasmacytoid dendritic cell neoplasms.
Leuk Lymphoma
; 63(7): 1754-1757, 2022 07.
Artigo
Inglês
| MEDLINE | ID: mdl-35253587
15.
CD99 as a novel therapeutic target on leukemic progenitor cells in FLT3-ITDmut AML.
Leukemia
; 36(6): 1685-1688, 2022 06.
Artigo
Inglês
| MEDLINE | ID: mdl-35422094
16.
Apoptosis and immaturity in acute myeloid leukemia.
Hematology
; 10(1): 25-34, 2005 Feb.
Artigo
Inglês
| MEDLINE | ID: mdl-16019442